N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142996 |
| CAS No | NA |
| Mol.F. | C187H290N46O60 |
| Mol.Wt. | 4142.64 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142997 |
| CAS No | NA |
| Mol.F. | C9H5CI2N5O2 |
| Mol.Wt. | 286.07 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142998 |
| CAS No | NA |
| Mol.F. | C9H4CI2N4O3 |
| Mol.Wt. | 287.06 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142999 |
| CAS No | NA |
| Mol.F. | C16H8CI4N6O2 |
| Mol.Wt. | 458.08 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143000 |
| CAS No | NA |
| Mol.F. | C9H6Cl2N6O |
| Mol.Wt. | 285.09 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143001 |
| CAS No | NA |
| Mol.F. | C9H8Cl2N6O |
| Mol.Wt. | 287.10 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143002 |
| CAS No | NA |
| Mol.F. | C9H6Cl2N6O2 |
| Mol.Wt. | 301.09g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143003 |
| CAS No | NA |
| Mol.F. | C23H10Cl6N6O3 |
| Mol.Wt. | 631.07 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143004 |
| CAS No | NA |
| Mol.F. | C9H6Cl2N6O2 |
| Mol.Wt. | 301.09g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143005 |
| CAS No | NA |
| Mol.F. | C16H8Cl4N6O2 |
| Mol.Wt. | 458.08 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143006 |
| CAS No | NA |
| Mol.F. | C19H13Cl4N11O |
| Mol.Wt. | 553.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143007 |
| CAS No | NA |
| Mol.F. | C19H13Cl4N11O |
| Mol.Wt. | 553.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143008 |
| CAS No | NA |
| Mol.F. | C8H7Cl2N5O2 |
| Mol.Wt. | 276.08 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143009 |
| CAS No | NA |
| Mol.F. | C16H13F3N4O4S |
| Mol.Wt. | 414.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143010 |
| CAS No | NA |
| Mol.F. | C7H5N3O2 |
| Mol.Wt. | 163.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143011 |
| CAS No | NA |
| Mol.F. | C14H11ClN4O2S |
| Mol.Wt. | 334.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |